vol
part
ongo
effort
public
health
agenc
canada
phac
enhanc
diseas
surveil
retrospect
epidemiolog
studi
undertaken
investig
use
influenza
surveil
data
chang
volum
prescript
antivir
medic
weekli
number
dispens
prescript
antivir
medic
oseltamivir
zanamivir
proport
dispens
prescript
compar
number
confirm
laboratori
report
influenza
local
health
author
level
ontario
canada
second
wave
outbreak
pandem
influenza
qualit
quantit
analys
demonstr
antivir
prescript
dispens
date
reason
proxi
influenza
onset
date
local
health
author
level
report
describ
result
analys
indic
antivir
prescript
proport
increas
advanc
laboratori
report
influenza
antivir
dispens
data
avail
near
realtim
find
suggest
pharmaci
prescript
data
provid
time
intellig
help
character
local
influenza
activ
valu
influenza
surveil
depend
part
timeli
gener
inform
tradit
method
influenza
surveil
includ
fluwatch
canada
nation
surveil
system
reli
collect
aggreg
laboratori
result
clinic
observ
physician
public
health
author
typic
infecti
diseas
take
sever
day
week
symptom
onset
data
collect
aggreg
analyz
pharmacybas
surveil
use
near
realtim
dispens
data
pharmaceut
prescript
overthecount
drug
proxi
ill
popul
potenti
pharmacybas
surveil
detect
chang
commun
ill
level
earlier
tradit
laboratorybas
surveil
method
premis
fact
public
routin
seek
overthecount
medic
reliev
allevi
common
symptom
ill
physician
often
prescrib
medic
receiv
laboratori
confirm
retrospect
diseas
outbreak
studi
demonstr
increas
pharmaceut
sale
recognit
increas
ill
frequenc
use
tradit
public
health
surveil
method
studi
proport
dispens
prescript
medic
oseltamivir
zanamivir
compar
week
number
confirm
laboratori
report
influenza
local
health
author
level
prescript
medic
data
provid
phac
rx
canada
inc
includ
individuallevel
prescript
data
approxim
ontario
commun
pharmaci
n
prescript
identifi
drug
date
dispens
patient
sex
age
laboratori
report
influenza
provid
phac
ontario
ministri
health
longterm
care
laboratori
report
provid
one
three
date
ill
onset
date
date
specimen
submit
laboratori
date
laboratori
result
report
public
health
author
case
onset
date
avail
estim
base
mean
time
differ
date
type
laboratori
report
includ
patient
age
sex
link
one
ontario
local
health
author
relationship
antivir
prescript
influenza
laboratoryconfirm
case
investig
use
poisson
regress
model
potenti
correl
local
health
author
level
accommod
use
gener
estim
equat
approach
determin
paramet
estim
weekli
antivir
prescript
dispens
antivir
per
prescript
compar
weekli
influenza
case
count
prescript
proport
use
rather
absolut
prescript
count
effort
adjust
number
potenti
factor
includ
dayofth
week
holiday
region
variat
physician
prescrib
pattern
lag
weekli
influenza
case
count
use
investig
potenti
timelag
influenza
symptom
onset
date
antivir
prescript
dispens
date
juli
inform
avail
approxim
ontario
oseltamivir
zanamivir
prescript
patient
age
sex
avail
antivir
prescript
mean
age
year
median
age
year
patient
femal
period
inform
avail
approxim
ontario
influenza
laboratori
confirm
mean
age
patient
year
median
age
year
femal
patient
symptom
onset
date
avail
case
laboratori
specimen
date
case
laboratori
report
date
case
averag
time
differ
mean
median
onset
date
mean
median
specimen
date
day
mean
median
specimen
date
mean
median
report
date
day
littl
lag
observ
influenza
case
onset
trend
line
antivir
prescript
trend
line
figur
poisson
regress
analysi
demonstr
statist
signific
relationship
weekli
influenza
case
count
antivir
prescript
local
health
author
level
p
statist
part
ongo
effort
public
health
agenc
canada
phac
enhanc
diseas
surveil
retrospect
epidemiolog
studi
undertaken
investig
use
influenza
surveil
data
chang
volum
prescript
antivir
medic
weekli
number
dispens
prescript
antivir
medic
oseltamivir
zanamivir
proport
dispens
prescript
compar
number
confirm
laboratori
report
influenza
local
health
author
level
ontario
canada
second
wave
outbreak
pandem
influenza
qualit
quantit
analys
demonstr
antivir
prescript
dispens
date
reason
proxi
influenza
onset
date
local
health
author
level
report
describ
result
analys
indic
antivir
prescript
proport
increas
advanc
laboratori
report
influenza
antivir
dispens
data
avail
near
realtim
find
suggest
pharmaci
prescript
data
provid
time
intellig
help
character
local
influenza
activ
valu
influenza
surveil
depend
part
timeli
gener
inform
tradit
method
influenza
surveil
includ
fluwatch
canada
nation
surveil
system
reli
collect
aggreg
laboratori
result
clinic
observ
physician
public
health
author
typic
infecti
diseas
take
sever
day
week
symptom
onset
data
collect
aggreg
analyz
pharmacybas
surveil
use
near
realtim
dispens
data
pharmaceut
prescript
overthecount
drug
proxi
ill
popul
potenti
pharmacybas
surveil
detect
chang
commun
ill
level
earlier
tradit
laboratorybas
surveil
method
premis
fact
public
routin
seek
overthecount
medic
reliev
allevi
common
symptom
ill
physician
often
prescrib
medic
receiv
laboratori
confirm
retrospect
diseas
outbreak
studi
demonstr
increas
pharmaceut
sale
recognit
increas
ill
frequenc
use
tradit
public
health
surveil
method
studi
proport
dispens
prescript
medic
oseltamivir
zanamivir
compar
week
number
confirm
laboratori
report
influenza
local
health
author
level
prescript
medic
data
provid
phac
rx
canada
inc
includ
individuallevel
prescript
data
approxim
ontario
commun
pharmaci
n
prescript
identifi
drug
date
dispens
patient
sex
age
laboratori
report
influenza
provid
phac
ontario
ministri
health
longterm
care
laboratori
report
provid
one
three
date
ill
onset
date
date
specimen
submit
laboratori
date
laboratori
result
report
public
health
author
case
onset
date
avail
estim
base
mean
time
differ
date
type
laboratori
report
includ
patient
age
sex
link
one
ontario
local
health
author
relationship
antivir
prescript
influenza
laboratoryconfirm
case
investig
use
poisson
regress
model
potenti
correl
local
health
author
level
accommod
use
gener
estim
equat
approach
determin
paramet
estim
weekli
antivir
prescript
dispens
antivir
per
prescript
compar
weekli
influenza
case
count
prescript
proport
use
rather
absolut
prescript
count
effort
adjust
number
potenti
factor
includ
dayofth
week
holiday
region
variat
physician
prescrib
pattern
lag
weekli
influenza
case
count
use
investig
potenti
timelag
influenza
symptom
onset
date
antivir
prescript
dispens
date
juli
inform
avail
approxim
ontario
oseltamivir
zanamivir
prescript
patient
age
sex
avail
antivir
prescript
mean
age
year
median
age
year
patient
femal
period
inform
avail
approxim
ontario
influenza
laboratori
confirm
mean
age
patient
year
median
age
year
femal
patient
symptom
onset
date
avail
case
laboratori
specimen
date
case
laboratori
report
date
case
averag
time
differ
mean
median
onset
date
mean
median
specimen
date
day
mean
median
specimen
date
mean
median
report
date
day
littl
lag
observ
influenza
case
onset
trend
line
antivir
prescript
trend
line
figur
poisson
regress
analysi
demonstr
statist
signific
relationship
weekli
influenza
case
count
antivir
prescript
local
health
author
level
p
statist
find
report
demonstr
second
wave
influenza
epidem
ontario
antivir
prescript
dispens
mirror
influenza
onset
activ
local
level
appreci
lag
time
result
suggest
pharmacybas
surveil
provid
mechan
monitor
detect
influenzalik
activ
regardless
whether
underli
pathogen
alreadi
known
topic
tradit
method
influenza
surveil
reli
collect
aggreg
laboratori
result
clinic
observ
physician
public
health
author
take
sever
day
week
symptom
onset
data
collect
aggreg
analyz
report
ad
report
chang
ratio
prescript
two
drug
prescrib
prophylaxi
treatment
influenza
prescript
coincid
second
wave
influenza
pandem
ontario
canada
juli
prescript
track
date
symptom
onset
ahead
date
posit
influenza
laboratori
report
local
health
author
level
implic
public
health
practic
infecti
diseas
mitig
strategi
effect
implement
earli
realtim
surveil
pharmaci
data
might
use
laboratori
data
guid
earli
implement
strategi
onset
date
move
avg
specimen
date
move
avg
report
date
move
avg
laboratori
confirm
might
especi
import
pathogen
routin
test
time
lag
symptom
onset
laboratori
report
public
health
offici
known
pathogen
substanti
even
second
wave
influenza
outbreak
public
health
author
ontario
prepar
averag
time
lag
symptom
onset
report
influenza
confirm
public
health
author
estim
day
caus
influenzalik
ill
unknown
routin
test
eg
novel
coronaviru
gain
achiev
timeli
pharmacybas
surveil
might
much
greater
report
posit
influenza
laboratori
result
commun
like
contribut
increas
physician
prescrib
antivir
howev
given
estim
lag
time
symptom
onset
laboratori
report
public
health
author
public
influenza
laboratori
confirm
like
influenc
prescript
pattern
earli
phase
increas
commun
activ
find
report
subject
least
three
limit
first
although
analysi
result
similar
regardless
whether
case
estim
onset
date
consid
valid
estim
onset
date
base
specimen
report
date
assess
second
proport
prescript
administ
prophylaxi
versu
treatment
known
neither
effect
might
tempor
associ
onset
date
prescript
dispens
date
final
studi
focus
one
event
influenza
pandem
addit
investig
involv
year
data
geograph
locat
requir
find
gener
although
laboratorybas
surveil
remain
cornerston
influenza
surveil
need
time
surveil
data
never
greater
routin
case
daili
movement
person
commun
infecti
diseas
rapidli
spread
around
world
matter
day
addit
much
learn
infecti
diseas
like
influenza
spread
method
use
help
minim
spread
potenti
impact
success
result
mitig
strategi
eg
cough
etiquett
hand
wash
stay
home
sick
vaccin
remind
best
achiev
implement
commun
earli
possibl
contribut
pharmacybas
surveil
overal
influenza
surveil
strategi
primarili
depend
timeli
pharmaci
data
canada
industri
nation
pharmaci
industri
maintain
sophist
inform
system
manag
drug
inventori
client
data
ongo
phac
realtim
pharmacybas
surveil
project
demonstr
collect
aggreg
analysi
near
realtim
prescript
data
thousand
commun
pharmaci
across
canada
readili
achiev
